Russell Investments Group, Ltd. Neu Base Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

  • $60.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$4.63 - $7.34 $100,248 - $158,925
-21,652 Closed
0 $0
Q4 2020

Feb 08, 2021
SELL
$6.92 - $9.25 $89,544 - $119,695
-12,940 Reduced 37.41%
21,652 $151,000
Q3 2020

Nov 09, 2020
BUY
$7.25 - $9.71 $205,552 - $275,297
28,352 Added 454.36%
34,592 $262,000
Q2 2020

Aug 05, 2020
BUY
$6.69 - $11.51 $41,745 - $71,822
6,240 New
6,240 $54,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email